PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Clinical trials for PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA explained in plain language.

Never miss a new study

Get alerted when new PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA trials appear

Sign up with your email to follow new studies for PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental injection aims to free patients from frequent blood draws

Disease control Ongoing

This study is testing whether a drug called sapablursen can help people with a blood disorder called polycythemia vera. The main goal is to see if the drug reduces how often patients need blood drawn to manage their condition and if it improves their quality of life. About 50 par…

Matched conditions: PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Get alerted when new PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA trials appear

Experimental injection aims to free patients from frequent blood draws